Renexxion, Inc.
PrivateLast Round
Reverse Merger
Mar 6, 2025
Company Overview
Renexxion, Inc. is a biotechnology company that develops pharmaceutical therapies for patients with gastrointestinal disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Renexxion, Inc. Comparables
Compare Renexxion, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Processa Pharmaceuticals | 85% | |
| Retromer Therapeutics | 83% | |
| Aclipse Therapeutics | 82% | |
Renexxion, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Reverse Merger | Mar 6, 2025 | ||||
| Private Placement | Apr 12, 2022 | ||||
| Angel | Sep 1, 2014 |
Renexxion, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Atheneos Ventures | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 6, 2025
Completed a reverse merger funding round.
- Apr 12, 2022
Raised a Private Placement round with investment from gemny.
Renexxion, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Renexxion, Inc.'s valuation, stock price, and market status.